Literature DB >> 12393939

Dominant negative mutants of filamin A block cell surface expression of the D2 dopamine receptor.

Ridwan Lin1, Victor Canfield, Robert Levenson.   

Abstract

Protein interaction screens have revealed an interaction between the D2 dopamine receptor and the actin cross-linking protein filamin A. However, the physiological significance of this interaction has not been explained. To better understand the role of filamin A in D2 receptor-mediated signaling, we examined the effect of disrupting filamin A/D2 receptor interaction. Overexpression of a truncated form of filamin A (repeat units 18-19 containing the D2, but not the actin, binding domain) caused a marked reduction in both the number and half-life of cell surface D2 receptors. These results suggest that disruption of the linkage between D2 receptors and the actin cytoskeleton destabilizes plasma membrane-associated D2 receptors. Several missense mutations within repeat unit 19 of filamin A were identified that abrogate filamin A/D2 receptor interaction. Introduction of mutant and wild-type filamin A into filamin A-deficient M2 cells demonstrated that wild-type filamin A, but not the filamin A-binding mutants, was able to promote cell-surface expression of D2 receptors. Together, these studies provide evidence that filamin A/D2 receptor interaction is required for the proper targeting or stabilization of D2 dopamine receptors at the plasma membrane. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393939     DOI: 10.1159/000065531

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  9 in total

Review 1.  Heptaspanning membrane receptors and cytoskeletal/scaffolding proteins: focus on adenosine, dopamine, and metabotropic glutamate receptor function.

Authors:  Francisco Ciruela; Laia Canela; Javier Burgueño; Ana Soriguera; Nuria Cabello; Enric I Canela; Vicent Casadó; Antonio Cortés; Josefa Mallol; Amina S Woods; Sergi Ferré; Carmen Lluis; Rafael Franco
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

2.  Filamin A promotes dynamin-dependent internalization of hyperpolarization-activated cyclic nucleotide-gated type 1 (HCN1) channels and restricts Ih in hippocampal neurons.

Authors:  Yoav Noam; Markus U Ehrengruber; Annie Koh; Paul Feyen; Erik M M Manders; Geoffrey W Abbott; Wytse J Wadman; Tallie Z Baram
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

3.  Identification of two functionally distinct endosomal recycling pathways for dopamine D₂ receptor.

Authors:  Yun Li; Brittany D Roy; Wei Wang; Li Zhang; Lifeng Zhang; Stephen B Sampson; Yupeng Yang; Da-Ting Lin
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

4.  Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motility.

Authors:  Leah Rider; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2011-05-12

5.  Imaging the Insertion of Superecliptic pHluorin-Labeled Dopamine D2 Receptor Using Total Internal Reflection Fluorescence Microscopy.

Authors:  Kathryn M Daly; Yun Li; Da-Ting Lin
Journal:  Curr Protoc Neurosci       Date:  2015-01-05

6.  Filamin a binds to CCR2B and regulates its internalization.

Authors:  Laura Minsaas; Jesús Planagumà; Michael Madziva; Beate F Krakstad; Míriam Masià-Balagué; Arieh A Katz; Anna M Aragay
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

7.  Desensitized D2 autoreceptors are resistant to trafficking.

Authors:  Brooks G Robinson; James R Bunzow; Jonathan B Grimm; Luke D Lavis; Joshua T Dudman; Jennifer Brown; Kim A Neve; John T Williams
Journal:  Sci Rep       Date:  2017-06-29       Impact factor: 4.379

Review 8.  Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.

Authors:  Claudia Pivonello; Roberta Patalano; Mariarosaria Negri; Rosa Pirchio; Annamaria Colao; Rosario Pivonello; Renata Simona Auriemma
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-12       Impact factor: 5.555

Review 9.  Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement.

Authors:  Erika Peverelli; Donatella Treppiedi; Elena Giardino; Eleonora Vitali; Andrea G Lania; Giovanna Mantovani
Journal:  Front Endocrinol (Lausanne)       Date:  2015-12-22       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.